Prulifloxacin in Chronic Bacterial Prostatitis (CBP)

• Status: Completed
• Trial end date: 2020-05-19

Summary

The aim of the study is to assess the efficacy and safety of prulifloxacin in comparison to levofloxacin in the treatment of patients affected by CBP.

• Phase: Phase 2

Details

• Lead Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A
• Collaborator: Hippocrates Research
• Treatments: Fluoroquinolones; Levofloxacin; Ofloxacin; Prulifloxacin